Tracheoscopic Management of Postoperative High Tracheoesophageal Fistula Using Covered Self-Expanding Metallic Stents: A Comparative Report of 2 Cases With Divergent Outcomes.

Am J Case RepOct 29, 2026 (epub)

Xiaodong Pang, Yili Chen, Yue Liu et al.

✦ AI-curated · Sources linked

Case in brief

Two men developed high tracheoesophageal fistulas after esophageal cancer surgery. In the 67-year-old, a 0.6 cm fistula 4 cm below the vocal folds was treated with a straight covered self-expanding metallic stent; after mucosal healing and epithelialization were confirmed, it was removed when granulation tissue hyperplasia was observed. In the 78-year-old man with diabetes, a larger 12×8 mm fistula 3 cm below the vocal folds was complicated by repeated stent displacement and impaired healing. A customized ball-ended stent, adjunctive materials, and ultimately external percutaneous fixation were used to stabilize it.

What made this case unusual

The contrasting courses illustrate the technical difficulty of stenting fistulas close to the vocal folds: a straight stent was successful in one case, whereas the other required a customized stent and external fixation after repeated displacement.

Diagnostic / clinical pearl

For high postoperative tracheoesophageal fistulas in the subglottic region, stent choice and adjunctive stabilization may need to be individualized when migration occurs.

Source

Published in Am J Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Otolaryngology (ENT)

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.